You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stupp

Showing 1 - 25 of 179
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, IDH-wildtype Trial in Beijing (Elemene, Placebo)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • Beijing, China
    Peking Union Medical College Hospital
Apr 22, 2023

Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))

Recruiting
  • Glioblastoma
  • GBM
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Nov 23, 2023

Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)

Recruiting
  • Anaplastic Oligoastrocytoma
  • Glioblastoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 27, 2022

Glioblastoma Trial (Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide))

Not yet recruiting
  • Glioblastoma
  • Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)
  • (no location specified)
Apr 20, 2022

Newly Diagnosed Glioblastoma Trial (Pembrolizumab)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • (no location specified)
Feb 22, 2022

MGMT-Unmethylated Glioblastoma Trial in Hangzhou (Anlotinib)

Recruiting
  • MGMT-Unmethylated Glioblastoma
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University School of
Jan 24, 2021

Glioblastoma Trial in Spain (TN-TC11G, Temozolomide Oral Product, Radiotherapy)

Not yet recruiting
  • Glioblastoma
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +7 more
Aug 2, 2022

Glioblastoma Trial in China (Anlotinib Hydrochloride, Placebo, Radiation Therapy)

Recruiting
  • Glioblastoma
  • Anlotinib Hydrochloride
  • +3 more
  • Bengbu, Anhui, China
  • +20 more
Jul 12, 2021

Glioblastoma Trial in France (Intensified protocol, Stupp protocol)

Recruiting
  • Glioblastoma
  • Intensified protocol
  • Stupp protocol
  • Amiens, France
  • +18 more
Jul 19, 2022

Initial Radiological Diagnosis Eligible for Tumor Resection, Initial Radiological Diagnosis Compatible With Newly Diagnosed

Recruiting
  • Initial Radiological Diagnosis Eligible for Tumor Resection
  • +2 more
  • SonoCloud-9 (SC9) device
  • Temozolomide according Stupp protocol
  • Leuven, Belgium
  • +6 more
Mar 28, 2022

Glioblastoma Trial in Guangzhou (anlotinib combined with dose-dense temozolomide)

Recruiting
  • Glioblastoma
  • anlotinib combined with dose-dense temozolomide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 11, 2020

Grade IV Astrocytoma, Glioblastoma Trial in France (Temozolomide, folinic acid at pharmacological dose is the escalated drug,

Terminated
  • Grade IV Astrocytoma
  • Glioblastoma
  • Angers, France
  • +3 more
May 20, 2021

Glioblastoma Trial in China (Anlotinib Hydrochloride, Radiation therapy, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Anlotinib Hydrochloride
  • +2 more
  • Guilin, Guangxi, China
  • +6 more
Nov 7, 2019

Glioblastoma Trial in Hangzhou (Anlotinib, Temozolomide Capsule)

Unknown status
  • Glioblastoma
  • Anlotinib
  • Temozolomide Capsule
  • Hangzhou, Zhejiang, China
    Zhejiang cancer hospital
Oct 6, 2019

stRess and exeRcize on the Outcome After Chemo-Radiation

Not yet recruiting
  • Glioblastoma (GBM)
  • Smartwatch
  • +2 more
  • Maastricht, Limburg, Netherlands
    Maastricht Radiation Oncology (Maastro)
Jun 21, 2022

Glioblastoma Trial in Rozzano (18F-GE-180 PET, Advanced MRI, Collection of hematopoietic stem cells)

Not yet recruiting
  • Glioblastoma
  • 18F-GE-180 PET
  • +4 more
  • Rozzano, (mi), Italy
    IRCCS Istituto Clinico Humanitas
Oct 27, 2023

Glioma, Malignant, Antigen-specific Vaccines, Individualized Treatment Trial in Shanghai (NeoPep Vaccine1 plus Poly-ICLC, NeoPep

Recruiting
  • Glioma, Malignant
  • +2 more
  • NeoPep Vaccine1 plus Poly-ICLC
  • NeoPep Vaccine2 plus Poly-ICLC
  • Shanghai, Shanghai, China
    Shanghai 10th People's Hospital
Oct 7, 2022

Recurrent Glioblastoma Multiforme Trial in Sao Paulo (Stereotactic hypofractionated RT 5x5Gy, Stereotactic hypofractionated RT

Active, not recruiting
  • Recurrent Glioblastoma Multiforme
  • Stereotactic hypofractionated RT 5x5Gy
  • Stereotactic hypofractionated RT 5x7Gy
  • Sao Paulo, SP, Brazil
    Hospital das Clinicas da Faculdade de Medicina da USP
Dec 15, 2021

Breast Carcinoma, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Chicago

Not yet recruiting
  • Breast Carcinoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Nov 14, 2023

Glioblastoma Multiforme Trial in Nice (Pazopanib)

Active, not recruiting
  • Glioblastoma Multiforme
  • Nice, Cedex 2, France
    Centre Antoine Lacassagne
Mar 3, 2022

Glioblastoma, IDH-wildtype, Metformin, Malignancies Trial in Milan (Metformin)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
Jun 26, 2023

Glioblastoma Multiforme Trial in Brno (11C-Methionine PET/CT)

Recruiting
  • Glioblastoma Multiforme
  • 11C-Methionine PET/CT
  • Brno, Czech Republic, Czechia
    Masaryk Memorial Cancer Institute
Nov 3, 2022

Glioblastoma Trial in Spain (PF-04449913, Temozolomide Oral Capsule)

Active, not recruiting
  • Glioblastoma
  • Badalona, Barcelona, Spain
  • +7 more
Feb 16, 2022

Glioblastoma Multiforme (Grade IV) of Cerebellum Trial in L'Hospitalet de Llobregat, Barcelona, Madrid (Crizotinib)

Completed
  • Glioblastoma Multiforme (Grade IV) of Cerebellum
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +3 more
Mar 9, 2022

Glioblastoma Trial in Berlin (Radiofrequency electromagnetic field treatment)

Recruiting
  • Glioblastoma
  • Radiofrequency electromagnetic field treatment
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Nov 15, 2023